These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8588240)

  • 1. Consensus guidelines for therapeutic drug monitoring of rapamycin: report of the consensus panel.
    Yatscoff RW; Boeckx R; Holt DW; Kahan BD; LeGatt DF; Sehgal S; Soldin SJ; Napoli K; Stiller C
    Ther Drug Monit; 1995 Dec; 17(6):676-80. PubMed ID: 8588240
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of therapeutic drug monitoring of rapamycin.
    Kahan BD; Napoli KL
    Transplant Proc; 1998 Aug; 30(5):2189-91. PubMed ID: 9723436
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential applications of therapeutic drug monitoring of sirolimus immunosuppression in clinical renal transplantation.
    Kahan BD; Murgia MG; Slaton J; Napoli K
    Ther Drug Monit; 1995 Dec; 17(6):672-5. PubMed ID: 8588239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
    Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
    Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry detection of intracytoplasmic cytokines after Neoral or sirolimus intake is an informative tool for monitoring in vivo immunosuppressive efficacy in renal transplant recipients.
    Tkaczuk J; Rostaing L; Puyoo O; Peres C; Abbal M; Durand D; Ohayon E
    Transplant Proc; 1998 Aug; 30(5):2400-1. PubMed ID: 9723518
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of rapamycin.
    Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Ann N Y Acad Sci; 1993 Jun; 685():121-2. PubMed ID: 8363216
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.
    Kahan BD; Chou T; Tejpal N; Wang M; Chee C; Stepkowski S
    Transplant Proc; 1994 Oct; 26(5):3021-4. PubMed ID: 7940951
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapamycin in experimental renal allografts in primates.
    Collier DS; Calne RY; Pollard SG; Friend PJ; Thiru S
    Transplant Proc; 1991 Aug; 23(4):2246-7. PubMed ID: 1871861
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
    Granger DK; Cromwell JW; Canafax DM; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretreatment of donors and grafts with rapamycin: the effect on graft survival and the tissue drug retention.
    Chen H; Sehgal S; Daloze P; Wu J
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):321-3. PubMed ID: 7554455
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation.
    Ochiai T; Gunji Y; Nagata M; Asano T; Isono K
    Transplant Proc; 1991 Dec; 23(6):2718-9. PubMed ID: 1721255
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of allograft rejection in vivo by rapamycin: molecular and cellular mechanisms of action.
    Morris RE
    Ann N Y Acad Sci; 1993 Jun; 685():68-72. PubMed ID: 8363274
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive properties of FK-506 and rapamycin.
    Thomson AW; Woo J
    Lancet; 1989 Aug; 2(8660):443-4. PubMed ID: 2474733
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
    Marquet RL; de Bruin RW; Heineman E; Jeekel J
    Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide.
    Eng CP; Gullo-Brown J; Chang JY; Sehgal SN
    Transplant Proc; 1991 Feb; 23(1 Pt 1):868-9. PubMed ID: 1990708
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.